Clemens von Birgelen

April 2, 2021 | 10.4244/EIJV16I18A266

BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial

Chang C, Kogame N, Asano T, von Birgelen C, Sabaté M, Onuma Y, Serruys P

December 4, 2020 | 10.4244/EIJ-D-19-00566

Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry

Mohamed M, Polad J, Hildick-Smith D, Bizeau O, Baisebenov R, Roffi M, Iniguez-Romo A, Chevalier B, von Birgelen C, Roguin A, Aminian A, Angioi M, Mamas MA

September 18, 2020 | 10.4244/EIJ-D-20-00361

Involving the patient’s perspective and preferences concerning coronary angiography and percutaneous coronary intervention

Kok M, von Birgelen C

February 20, 2020 | 10.4244/EIJV15I14A221

Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

Haude M, Ince H, Toelg R, Lemos P, von Birgelen C, Christiansen E, Wijns W, Neumann F, Eeckhout E, Garcia-Garcia H, Waksman R

February 7, 2020 | 10.4244/EIJ-D-18-01000

The obesity paradox revisited: body mass index and long-term outcomes after PCI from a large pooled patient-level database

Wolny R, Maehara A, Liu Y, Zhang Z, Mintz G, Redfors B, Madhavan M, Smits P, von Birgelen C, Serruys P, Mehran R, Leon M, Stone G

January 17, 2020 | 10.4244/EIJ-D-19-00467

Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention

Brener S, Leon M, Serruys P, Smits P, von Birgelen C, Mehran R, Kirtane A, Witzenbichler B, Rinaldi M, Metzger C, Mazzaferri E, Zhang Z, Stone G

August 9, 2019 | 10.4244/EIJ-D-19-00262

Reply to the letter to the editor regarding the article “Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population”

Kok M, Sattar N, von Birgelen C

February 7, 2019 | 10.4244/EIJ-D-18-00235R

Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial

Kok M, Zocca P, Buiten R, Danse PW, Schotborgh C, Scholte M, Hartmann M, Stoel M, van Houwelingen K, Linssen GCM, Doggen CJM, von Birgelen C

October 19, 2018 | 10.4244/EIJ-D-18-00336

Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population

Kok M, von Birgelen C, Sattar N, Zocca P, Löwik M, Danse PW, Schotborgh C, Scholte M, Hartmann M, Kant GD, Doelman CJA, Gin M, Stoel M, van Houwelingen K, Linssen GCM, IJzerman M, Doggen CJM, van der Heijden LC

October 12, 2018 | 10.4244/EIJ-D-17-01067

Is the proximal left anterior descending coronary artery segment justifiably considered as the last frontier for stenting?

Roguin A, Solomonica A, von Birgelen C

September 20, 2018 | 10.4244/EIJV14I7A127

Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy

Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernández-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber J, von Birgelen C, Sabaté M, Onuma Y, Serruys P

August 3, 2018 | 10.4244/EIJ-D-17-00461

First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial

von Birgelen C, Asano T, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernández-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Onuma Y, Serruys P, Sabaté M

April 20, 2018 | 10.4244/EIJ-D-17-00462

Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT

Zocca P, van der Heijden LC, Kok M, Löwik M, Hartmann M, Stoel M, Louwerenburg H, de Man F, Linssen GCM, Knottnerus I, Doggen CJM, van Houwelingen K, von Birgelen C

November 20, 2017 | 10.4244/EIJ-D-17-00634

Clinical outcomes after percutaneous coronary intervention with the COMBO stent versus Resolute Integrity and PROMUS Element stents: a propensity-matched analysis

Kalkman D, Kok M, van der Heijden LC, Woudstra P, Beijk M, Thijssen J, von Birgelen C, de Winter R

November 20, 2017 | 10.4244/EIJ-D-17-00301

A novel four-dimensional angiographic approach to assess dynamic superficial wall stress of coronary arteries in vivo: initial experience in evaluating vessel sites with subsequent plaque rupture

Wu X, von Birgelen C, Muramatsu T, Li Y, Holm N, Reiber J, Tu S

October 11, 2017 | 10.4244/EIJ-D-16-01020

Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III

Haude M, Ince H, Kische S, Abizaid A, Toelg R, Lemos P, Van Mieghem N, Verheye S, von Birgelen C, Christiansen E, Wijns W, Garcia-Garcia H, Waksman R

July 20, 2017 | 10.4244/EIJ-D-17-00254

First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis

Suwannasom P, Sotomi Y, Corti R, Kurz D, Roffi M, von Birgelen C, Buzzi S, Zucker A, Dijkstra J, Wykrzykowska J, de Winter R, Windecker S, Onuma Y, Serruys P, Daemen J, Räber L

April 20, 2017 | 10.4244/EIJ-D-16-00975

Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trial

van der Heijden LC, Kok M, Löwik M, Danse PW, Jessurun G, Hautvast R, van Houwelingen K, Stoel M, Hartmann M, Linssen GCM, Doggen CJM, von Birgelen C

April 20, 2017 | 10.4244/EIJ-D-16-00571

Evaluation of vascular healing of polymer-free sirolimus-eluting stents in native coronary artery stenosis: a serial follow-up at three and six months with optical coherence tomography imaging

Suwannasom P, Onuma Y, Benit E, Gach O, von Birgelen C, Hofma S, Sotomi Y, Bo X, Zhang Y-J, Gao R, Garcia-Garcia H, Wykrzykowska J, de Winter R, Serruys P

August 5, 2016 | 10.4244/EIJV12I5A97

Clemens von Birgelen

Latest news